OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN:…
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025 NANTES, France, June 11, 6:30 PM – OSE Immunotherapeutics…
June 06, 2025 12:30 ET | Source: IDEX BIOMETRICS ASA Reference is made to the stock exchange notice from IDEX…
Press release Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of…